BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 536437)

  • 1. Fluorimetric determination of atenolol in plasma and urine by direct evaluation of thin-layer chromatograms.
    Schäfer M; Mutschler E
    J Chromatogr; 1979 Feb; 169():477-81. PubMed ID: 536437
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid determination of atenolol in human plasma and urine by high-pressure liquid chromatography.
    Weddle OH; Amick EN; Mason WD
    J Pharm Sci; 1978 Jul; 67(7):1033-5. PubMed ID: 660497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electron-capture-gas chromatographic determination of atenolol in plasma and urine, using a simplified procedure with improved selectivity.
    Ervik M; Kylberg-Hanssen K; Lagerström PO
    J Chromatogr; 1980 Jun; 182(3-4):341-7. PubMed ID: 7391176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
    Bühring KU; Garbe A
    J Chromatogr; 1986 Oct; 382():215-24. PubMed ID: 2878004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atenolol determination by high-performance liquid chromatography and fluorescence detection.
    Yee YG; Rubin P; Blaschke TF
    J Chromatogr; 1979 Apr; 171():357-62. PubMed ID: 546856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spectrofluorimetric estimation in biological fluids of a new beta-blockader: atenolol. Application to its pharmacokinetic study (author's transl)].
    Flouvat B; Bazin M; Lucsko M; Roux A; Guedon J
    Ann Biol Clin (Paris); 1978; 36(4):339-46. PubMed ID: 32816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient assay for the determination of atenolol in human plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Chiu FC; Zhang JN; Li RC; Raymond K
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 691(2):473-7. PubMed ID: 9174286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thin-layer chromatographic analysis of some beta-blocking drugs in plasma.
    Witek A; Przyborowski L
    Acta Pol Pharm; 1997; 54(3):183-6. PubMed ID: 9511444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination in biologic media of a new beta-blocker, atenolol, by high performance liquid chromatography].
    Decourt S; Flouvat B
    J Chromatogr; 1979 Jun; 174(1):258-63. PubMed ID: 546890
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct enantiospecific HPLC bioanalysis of (R,S)-atenolol on a chiral stationary phase.
    Kofahl B; Henke D; Mutschler E
    Chirality; 1993; 5(6):479-82. PubMed ID: 8398605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved high-performance liquid chromatography assay for atenolol in plasma and urine using fluorescence detection.
    Morris RG; Saccoia NC; Sallustio BC; Zacest R
    Ther Drug Monit; 1991 Jul; 13(4):345-9. PubMed ID: 1780968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exercise on renal clearance of atenolol.
    Mason WD; Kochak G; Winer N; Cohen I
    J Pharm Sci; 1980 Mar; 69(3):344-5. PubMed ID: 7381717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of atenolol in plasma by dual-column liquid chromatography and fluorimetric detection.
    Johannsson M; Forsmo-Bruce H
    J Chromatogr; 1988 Nov; 432():265-72. PubMed ID: 3220893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation and quantitation of (R)- and (S)-atenolol in human plasma and urine using an alpha 1-AGP column.
    Enquist M; Hermansson J
    Chirality; 1989; 1(3):209-15. PubMed ID: 2642050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorimetric determination of maprotiline in urine and plasma after thin-layer chromatographic separation.
    Prinoth M; Mutschler E
    J Chromatogr; 1984 Feb; 305(2):508-11. PubMed ID: 6707178
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma levels of atenolol after haemodialysis in patients with end stage renal disease.
    Rosseel MT; Bogaert MG; Christiaens M; Verpooten GA; De Broe ME
    Arch Int Pharmacodyn Ther; 1979 May; 239(1):176. PubMed ID: 485716
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fluorometric determination of plasma niflumic acid by direct estimation of thin layer chromatograms].
    Schumacher A; Geissler HE; Mutschler E
    J Chromatogr; 1979 Mar; 162(3):489-93. PubMed ID: 528619
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluorimetric determination of dimethylaminohydroxypropoxytriamterene in biological fluids by direct evaluation of thin-layer chromatograms.
    Kraft H; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1542-4. PubMed ID: 4074411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ranitidine on plasma metoprolol and atenolol concentrations.
    Spahn H; Mutschler E; Kirch W; Ohnhaus EE; Janisch HD
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1546-7. PubMed ID: 6133576
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein binding of atenolol and propranolol to human serum albumin and in human plasma [proceedings].
    Barber HE; Hawksworth GM; Kitteringham NR; Petersen J; Petrie JC; Swann JM
    Br J Clin Pharmacol; 1978 Nov; 6(5):446P-447P. PubMed ID: 728297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.